Skip to main content

Year: 2025

From 8.3 – Bluefield Solar Income Fund Ltd.

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Bluefield Solar Income Fund Ltd(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an...

Continue reading

Enwex U.K. Onshore Wind Futures Now Live for Trading on Abaxx Exchange

The contract serves as the exclusive benchmark for the Enwex U.K. Wind Index TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, today announced that trading has commenced in Enwex U.K. Onshore Wind (UWM) futures, the second contract in Abaxx Exchange’s growing suite of weather derivatives. Following the launch of Enwex German Onshore Wind Futures, the U.K. contract addresses the unique risk profile of one of Europe’s most wind-dependent power markets, where Atlantic...

Continue reading

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path

Consistent OS benefit in an Asian subset with a strong HR of 0.69 for non-squamous patients, and meaningful safety advantage position Plinabulin as a late-stage candidate showing survival improvement in 2L/3L EGFR WT NSCLC.FLORHAM PARK, N.J., Dec. 12, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI), a clinical-stage biopharmaceutical company developing first-in-class immune-modulating cancer therapies, today announced results from the Asian subset (n=488) of its global Phase 3 DUBLIN-3 trial evaluating Plinabulin plus docetaxel compared to docetaxel alone in second- or third-line EGFR wild-type non-small cell lung cancer (NSCLC). Dublin-3’s global intent-to-treat (ITT) patient data was published in Lancet Respiratory Medicine in 2024. These new findings were presented by Dr. Baohui Han of Shanghai Chest Hospital at the...

Continue reading

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

BANNOCKBURN, Ill., Dec. 12, 2025 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 44th Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 13, 2026, including a presentation at 10:30am PT. The webcast and related presentation materials will be available online at https://investors.optioncarehealth.com. About Option Care Health Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership,...

Continue reading

Ellomay Capital Announces FER X “NZIA” Tender Award for an RtB 20 MW Solar Project in Piemonte, Italy

Tel-Aviv, Israel, Dec. 12, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and USA, today announced that Ellomay Solar Italy Fourteen S.r.l. (an Italian project company 100% owned by the Company), was informed that it has been awarded a tariff in Italy’s Transitional FER X “NZIA” national competitive tender (which provides a beneficial pricing arrangement described in more detail below) for solar plants using non-Chinese components, securing support for 80% of the capacity of its Ready-to-Build solar project “Ellomay 14”, which is located in the Piemonte Region in Italy. The Ellomay 14 project has peak capacity of 20 MWp, with an expected annual generation (P50) of...

Continue reading

Ferrellgas Partners, L.P. Reports First Quarter Fiscal Year 2026 Results

LIBERTY, Mo., Dec. 12, 2025 (GLOBE NEWSWIRE) — Ferrellgas Partners, L.P. (OTC: FGPR) (“Ferrellgas” or the “Company”) today reported financial results for its 2026 first fiscal quarter ended October 31, 2025. “Ferrellgas had a strong start to fiscal 2026,” said Tamria Zertuche, President and CEO. “In the first quarter, our employee-owners delivered strong operational results, and we successfully refinanced the notes due 2026 and our revolving credit facility. With this momentum, along with our recent credit rating upgrades from S&P Global and Moody’s, our team remains focused on running the business efficiently and executing strategies that strengthen our performance. Due to the ongoing improvements in telematics, routing optimization, and our safety programs, we are confident and well prepared for the upcoming winter heating...

Continue reading

Johnson Outdoors Reports Results for Fiscal Year 2025

RACINE, Wis., Dec. 12, 2025 (GLOBE NEWSWIRE) — Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor recreation equipment and technology, today announced operating results for the fiscal year ending October 3, 2025. “New product successes drove positive momentum in the second half of the year, resulting in a solid finish to our 2025 fiscal year,” said Helen Johnson-Leipold, Chairman and Chief Executive Officer. “In the midst of ongoing uncertainties in the marketplace, we continue to invest and execute on our strategic priorities—innovation, operational efficiencies, and ecommerce. We are confident these are the right drivers for future company success.” FISCAL 2025 RESULTSAfter a slow start to the beginning of the fiscal year, the Company saw double-digit growth in the second half of the year.   Total revenue...

Continue reading

PhenixFIN Corporation Announces Fiscal Year and Fourth Quarter 2025 Financial Results

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) — PhenixFIN Corporation (NASDAQ: PFX, PFXNZ) (the “Company”), a publicly traded business development company, today announced its financial results for the fiscal year and the fourth fiscal quarter of 2025. HighlightsFourth quarter total investment income of $6.9 million; net investment income of $1.4 million Net asset value (NAV) of $160.8 million, or $80.24 per share as of September 30, 2025, vs. $79.37 per share as of September 30, 2024 Weighted average yield was 12.8% on debt and other income producing investments as of the fiscal year endDavid Lorber, Chief Executive Officer of the Company, stated: “Throughout fiscal year 2025, we remained focused on executing our strategy to grow NAV per share and enhance shareholder value. We continued our share repurchase program...

Continue reading

Finanskalender 2026 og 2027

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10 Brøndby, den 12. december 2025 SELSKABSMEDDELELSE NR. 15/2025 Brøndbyernes IF Fodbold A/S – Finanskalender 2026 og 2027 Brøndbyernes IF Fodbold A/S har planlagt følgende datoer for meddelelser og ordinære generalforsamlinger i resten af 2025 og for 2026. 12. februar 2026:         Delårsrapport H1 2025 for perioden 1. juli 2025 – 31. december 2025* 24. september 2026:        Årsrapport 2025/26 for perioden 1. juli 2025 – 30. juni 2026 20. oktober 2026:        Ordinær generalforsamling 11. februar 2027:         Delårsrapport H1 2026 for perioden 1. juli 2026 – 31. december 2026 23. september 2027:         Årsrapport 2026/27 for perioden 1. juli 2026 – 30. juni 2027 19. oktober 2027:         Ordinær generalforsamling *Bemærk venligst, at delårsrapporten H1 2025 for perioden 1. juli 2025 – 31....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.